Paradigm Medical Ind Stock Net Income
| PDMI Stock | USD 0.0001 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Paradigm Medical, as well as the relationship between them.
Paradigm Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Paradigm Medical's valuation are provided below:Paradigm Medical Ind does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Paradigm |
Paradigm Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Paradigm Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Paradigm Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Paradigm Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Paradigm Medical Ind or generate 0.0% return on investment in Paradigm Medical over 90 days. Paradigm Medical is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of ... More
Paradigm Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Paradigm Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Paradigm Medical Ind upside and downside potential and time the market with a certain degree of confidence.
Paradigm Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Paradigm Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Paradigm Medical's standard deviation. In reality, there are many statistical measures that can use Paradigm Medical historical prices to predict the future Paradigm Medical's volatility.Paradigm Medical Ind Backtested Returns
We have found three technical indicators for Paradigm Medical Ind, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Paradigm Medical are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Paradigm Medical Ind has perfect predictability. Overlapping area represents the amount of predictability between Paradigm Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Paradigm Medical Ind price movement. The serial correlation of 1.0 indicates that 100.0% of current Paradigm Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Paradigm Medical Ind reported net income of (474,000). This is 100.14% lower than that of the Health Care Equipment & Supplies sector and 100.48% lower than that of the Health Care industry. The net income for all United States stocks is 100.08% higher than that of the company.
Paradigm Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Paradigm Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Paradigm Medical could also be used in its relative valuation, which is a method of valuing Paradigm Medical by comparing valuation metrics of similar companies.Paradigm Medical is currently under evaluation in net income category among its peers.
Paradigm Fundamentals
| Return On Asset | -0.14 | |||
| Profit Margin | (0.46) % | |||
| Operating Margin | (0.27) % | |||
| Current Valuation | 649.76 K | |||
| Shares Outstanding | 3.25 B | |||
| Price To Sales | 0.01 X | |||
| Revenue | 772 K | |||
| Gross Profit | 525 K | |||
| EBITDA | (204 K) | |||
| Net Income | (474 K) | |||
| Cash And Equivalents | 21 K | |||
| Total Debt | 615 K | |||
| Current Ratio | 0.18 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (74 K) | |||
| Beta | -30.75 | |||
| Market Capitalization | 6.5 K | |||
| Total Asset | 895 K | |||
| Retained Earnings | (64.69 M) | |||
| Working Capital | (2.38 M) | |||
| Current Asset | 476 K | |||
| Current Liabilities | 2.86 M | |||
| Net Asset | 895 K |
About Paradigm Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Paradigm Medical Ind's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Paradigm Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Paradigm Medical Ind based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Paradigm Pink Sheet
Paradigm Medical financial ratios help investors to determine whether Paradigm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paradigm with respect to the benefits of owning Paradigm Medical security.